Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Astellas to Transfer Manufacturing Plant in Netherlands to French Firm
May 26, 2023
- Clinical Trial Notification Filed for RPE Tear Cell Therapy: Sumitomo/Healios
May 26, 2023
- GSK’s Pediatric Antibiotic Clavamox to Be Out of Stock on Demand Spike
May 25, 2023
- Some 400 General Employees Likely Leaving Bayer under Redundancy Program
May 25, 2023
- Lilly’s Omvoh Launch Set for June 21; BioMarin’s Palynziq Now Available
May 25, 2023
- Novartis Japan Rolling Out New Operational Model Tailored to Local Needs: President
May 24, 2023
- Mitsubishi Tanabe to Refine Growth Scenario, Expand Overseas Operations under New Leadership
May 24, 2023
- Oncodesign, Veritas Form Collab for mRNA Drug Development
May 24, 2023
- Lecanemab Filed in UK, Designated under Innovative Pathway: Eisai/Biogen
May 23, 2023
- Sawai and Towa Profits Tank 50% on Flat Sales in Japan: FY2022 Earnings
May 22, 2023
- Astellas CEO Confident about Veozah Uptake, 500 Billion Yen Sales Potential
May 22, 2023
- Mounjaro No. 1 in GP Promotion in March, Dayvigo Most Detailed for HPs
May 22, 2023
- Nipro’s Nexium AG Grabs 53% Market Share in Just 4 Months
May 22, 2023
- Daiichi Sankyo Begins Japan PIII for Omicron-Tailored Jab
May 22, 2023
- Top 4 Wholesalers on Solid Note with 30% Operating Profit Rise in FY2022
May 19, 2023
- Taiho Seals Trial Pact for Arcus Oncology Meds to Work with Gilead
May 19, 2023
- Qol to Further Expand Espha's AG Biz, Eyes Biosame Territory: Exec
May 19, 2023
- BMS Files Luspatercept for MDS Associated Anemia in Japan
May 19, 2023
- Lecanemab’s Social Value in Japan Simulated at 4.7 Million Yen per Patient/Year: Eisai
May 18, 2023
- Xocova Makes Up 11% of COVID Oral Drug Prescriptions Filled Outside Pharmacies
May 18, 2023
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…